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Abstract In order to understand how lungs of healthy people,
unlike those of cystic fibrosis (CF) patients, are protected against
bacterial infections such as Pseudomonas aeruginosa, the
following three key findings were made. First, P. aeruginosa do
not multiply when planted onto tracheal epithelial cells from
healthy humans but do so profusely on cells from vF508 CF
patients. Second, some bacteria bind, and gain entrance into CF
cells, even at a physiological salt concentration (104 mM). Third,
human tracheal epithelial cells express an V4 kDa peptide
(hTAP), which is known in its bovine form to exhibit bactericidal
action against P. aeruginosa. A model is proposed depicting both
how normal epithelial cells, in a first-line self defense mechanism,
may be protected against bacterial infection and how this
mechanism may fail during the initial stages of CF.
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1. Introduction
The disease cystic ¢brosis is an inherited disorder that af-
fects approximately 1 in 2000 people in the United States and
Canada. Individuals with severe cases frequently die before
the age of 30. The disease is characterized by lung dysfunc-
tion, pancreatic insu¤ciency, and increased sweat chloride
concentration. Cystic ¢brosis is caused by mutations in the
CFTR protein, a chloride channel [1]. The most common
mutation, the deletion of Phe-508 (vF508), results in chronic
infections by Pseudomonas aeruginosa in the lungs of CF pa-
tients.
Despite much recent work, both on the ¢rst nucleotide
binding domain of the CFTR protein in which the vF508
mutation resides [2^6], and on the pathogenesis of CF [7^
10], the mechanism by which CF patients acquire chronic
lung infections is unclear. In one recent report [9] it is con-
cluded that infectious P. aeruginosa enter normal tracheal
epithelial cells but not CF cells, the implication being that a
normal cell's ability to combat bacterial infection is dependent
on bacterial entry, which in turn is dependent on normal
CFTR function. In a second intriguing report [10], it is sug-
gested that, rather than `engul¢ng' invading bacteria, normal
tracheal cells secrete an antibacterial agent, a defense mecha-
nism rendered impotent in CF cells, presumably because of a
higher NaCl concentration in the airway £uid resulting from
mutated CFTR. Finally, in a third study, [11] evidence is
provided that P. aeruginosa interact directly with normal
and CF cells via asialoganglioside 1, the postulated receptor,
and that increased amounts of this receptor in CF cells may
help explain the pathogenesis. Although there are apparent
di¡erences among these studies, the general implication is
that P. aeruginosa have a propensity to localize more near
CF cells than normal cells.
Below we brie£y summarize studies carried out to under-
stand the cellular and biochemical basis of CF pathogenesis.
These studies entail both an extensive ultrastructural analysis
of several thousand normal and CF human epithelial cells
exposed to P. aeruginosa, and the cloning and sequencing
from human tracheal epithelial cells of a small peptide known
to exhibit bactericidal action against these bacteria. Collec-
tively, these studies provide a novel model to explain how
normal tracheal epithelial cells in a `¢rst-line defense' process
combat bacterial infections while CF cells fail to do so.
2. Materials and methods
2.1. Materials
The NHBE primary cells, which are predominantly tracheal epithe-
lial cells, and BEGM (a modi¢ed version of LHC8 medium) were
from clonetics. HTE and CFTE cell lines were gifts from Dr. D.
Gruenert of USCSF. The CFPAC cell line, and the mucoid form of
P. aeruginosa, obtained from the sputum of a CF patient, were from
ATCC. The doubling time of P. aeruginosa in tryptic soy broth me-
dium (Difco) was about 20 min. The RNA PCR Kit, and the template
and primers used in studies of hTAP were from Perkin Elmer. The
Puregene DNA Isolation Kit was obtained from Gentra, and both
Dulbecco's phosphate-bu¡ered saline and trizol were from Gibco
BRL. The Oligotex Direct mRNA Puri¢cation Kit, Quiaquick Gel
Extraction Kit, and Plasmid Miniprep Kit were purchased from Quia-
gen. PCR primers were synthesized in the Johns Hopkins University
core facility. The microwave oven (Model 3400) and the 200 mesh
copper grids were from Pelco.
2.2. DNA sequencing
DNA templates for the automated DNA sequencing reaction were
obtained after purifying the PCR ampli¢ed products from 3% low
melting point NuSieve GTG agarose gels. For NHBE, HTE, and
CFPAC cells, total RNA was isolated from these cells and respective
cDNAs were synthesized for RT-PCR according to the method de-
scribed under Fig. 3. In the case of the CFTE cells, the genomic DNA
was prepared from the cell lysate by use of Gentra's Purengene DNA
Isolation Kit which was used as the template for PCR synthesis of the
F508 region of CFTR. The sequence of the primers employed for the
PCR were as follows: 5P primer: base G1548^base T1565 (18-mer);
3P primer: base G1685^C1708 (24-mer).
2.3. Infection of epithelial cells with P. aeruginosa and transmission
electron microscopy
The trypsinized epithelial cells (V10
6
cells) were seeded onto poly-
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carbonate Snapwell membranes (growth area=1 cm
2
) and cultivated
for 5 days in a 37³C incubator supplemented with 5% CO
2
. Then,
freshly grown P. aeruginosa (A
600nm
=0.5) were diluted with BEGM
(modi¢ed version of LHC8 medium containing 104 mM NaCl), to
provide bacteria to epithelial cell ratios of 1:300, 1:30, or 1:1 in
100 Wl. This volume was more than su¤cient to cover all cells, and
an increase to 500 Wl did not alter the outcome of experiments de-
scribed below. The apical sides of epithelial cells was exposed to
bacteria for 10 h at 37³C. After this infection period, cells on the
membrane were rinsed with 1UPBS and ¢xed with 2 ml of parafor-
maldehyde plus 2% glutaraldehyde in 1UPBS, pH 7.4, with the top
plate covered. The cells in the ¢xative above were placed in a water
bath inside a microwave oven and samples were microwave pulsed
according to [12,13] with a 10 s pulse/20 s rest/10 s pulse, maintaining
100% power at each step. The ¢xative temperature did not exceed
30³C. Cells were allowed to remain in the ¢xative for an additional
5 min and brie£y rinsed in PBS, followed by a rinse with 0.2 M
sodium cacodylate.





in 1% osmium tetroxide, rinsed in distilled water, and stained in ¢l-
tered 1% aqueous uranyl acetate for 15 min. Treated cells on the
membrane were quickly dehydrated in a graded series of ethanol
washes, in¢ltrated with eponate, and cured ¢rst in an oven for
3 days at 37³C and then overnight at 60³C. Ultrathin sections (80
nm) were cut horizontally or vertically on a low angle Diatome dia-
mond knife and collected on 200 mesh copper grids. Sections were
additionally stained with 2% aqueous uranyl acetate for 25 min,
rinsed, and allowed to dry. Samples were viewed on a Zeiss 10 B
Transmission Electron Microscope operating at 60 kV.
2.4. Expression and sequence of hTAP
Total RNA or mRNA from NHBE and T84 cells grown to con-
£uency on T-75 £asks was prepared by employing Trizol and an
Oligotex Direct mRNA Puri¢cation Kit, respectively. According to
the protocol provided by Perkin Elmer's RNA PCR kit, cDNAs
were synthesized from the RNA prepared as above and were used
as templates for RT-PCR under the following conditions: reverse
transcription reaction: 10 min at 25³C (ambient temperature), 15
min at 42³C, 5 min at 99³C, and 5 min at 4³C; PCR: 2 min at
95³C, one cycle; followed by 35 cycles of 1 min at 95³C, 1 min at
55³C, and 3 min at 72³C; ¢nally, 10 min at 72³C, one cycle. The RT-
PCR ampli¢ed products were then analyzed by agarose gel (1.4%)
electrophoresis, after which the bands having the expected molecular
mass of 220 bp were excised from the gel, puri¢ed using the method of
Qiagen's Qiaquick Gel Extraction Kit, and ¢nally ligated into TA
cloning sites of the TA cloning Kit Vector pCR II. TA Cloning
One Shot competent cells were used and transformed by the ligation
mixture above. The resultant recombinant plasmid was puri¢ed by use
of Qiagen's Plasmid Miniprep Kit and 3 Wg was subjected to auto-
mated DNA sequencing analysis with the T7 promoter sequence as
the sequencing primer.
3. Results and discussion
In order to understand better how normal human epithelial
cells combat bacterial infections whereas CF cells do not, we
studied a normal human tracheal epithelial cell line (HTE)
and two cell lines from humans a¥icted with CF, i.e. CFTE
cells from the trachea and CFPAC cells from the pancreas.
The vF508 genotype of CFTR and CFPAC cells was con-
¢rmed (Fig. 1D and E, respectively) by use of PCR and auto-
mated DNA sequencing [14^16]. The DNA sequence of
CFTR in the HTE cell line and in NHBE primary cells,
also used in this study, was normal in the F508 region (Fig.
1C and B, respectively).
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Fig. 1. Con¢rmation of the genotypes of the cells employed by
DNA sequencing near the F508 region. (A) The DNA sequence of
CFTR near the F508 region (from N505 to S511) is shown to de-
pict the vF508 mutation resulting from deleting C TT (represented
as a bar across the sequence). NHBE (B) and HTE (C) cells contain
the predicted wild-type CFTR DNA sequence, near the F508 re-
gion, whereas CFTE (D) and CFPAC (E) cells show that C TT has
been deleted without generating a frame shift, thus resulting in the
vF508 mutation. The antisense DNA is sequenced in HTE cells and
the arrow indicates the direction of the sense DNA.
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Following the establishment of cell genotypes, bacterial in-
fection experiments were conducted to determine how normal
and CF cells interact with P. aeruginosa. Cells were grown on
a permeable ¢lter support (Snapwell polycarbonate mem-
brane) to improve cell di¡erentiation. Subsequently, they
were exposed to P. aeruginosa from the apical side for 10 h
at 37³C. Bacteria were diluted in BEGM, a modi¢ed version
of LHC8 medium having a NaCl concentration of 104 mM,
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Fig. 2. Ultrastructural analysis by TEM on horizontally cut thin sections. (A) Normal (HTE) cells after 10 h exposure to P. aeruginosa. The
bacterial infection has cleared and no free £oating or bound bacteria are observed. N and PM designate the nucleus and plasma membrane, re-
spectively. (Inset) P. aeruginosa observed after 10 h in the absence of HTE cells. The scale bar represents 10 Wm in (A,B), and 1 Wm in the in-
set. (B^D) CFTE cells (vF508 CF tracheal cells) infected with P. aeruginosa. Binding of the bacteria to CFTE cells (single arrows) and their
growth on or near the microvilli of these cells is clearly observed (B,C). CFTE cells in which P. aeruginosa gained entrance are shown in C,D.
Scale bars = 1 Wm. (E,F) CFPAC cells (vF508 CF pancreatic cells) after infection with P. aeruginosa. CFPAC cells were unable to clear the bac-
terial infection. Rather, P. aeruginosa were found to bind and enter these cells. The scale bar is 10 Wm in length (E). Higher magni¢cation (F,
scale bar= 1 Wm) clearly shows that P. aeruginosa both bind (single arrows) and enter (double arrows) CFPAC cells. (See Table 1 for bacteria/
cell infection ratios for A^F.)
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considered to be in the normal physiological range for airway
surface £uid [17,18]. Inspection of horizontally cut thin sec-
tions of the normal cells by TEM after a 10 h exposure to P.
aeruginosa, as shown in Fig. 2A, did not reveal any free £oat-
ing bacteria, although in companion experiments conducted in
the absence of epithelial cells numerous bacteria were present
(Fig. 2A, inset). Furthermore, in micrographs not presented
here, some normal cells were seen to continue with mitosis.
These experiments demonstrate that normal tracheal epithelial
cells exhibit the capacity to clear (`kill') these bacteria during a
10 h incubation period while maintaining growth. Even when
the infection ratio of P. aeruginosa to normal cells was in-
creased from 1:300 (Fig. 2A) to 1:1, these cells were able to
resist the bacterial attack and completely clear the surround-
ing bacteria. In sharp contrast, the CF vF508 cells (CFTE)
were unable to clear the surrounding bacteria. Consequently,
these bacteria multiplied substantially. Some became bound to
the epithelial cells, interacting with the microvilli, (Fig. 2B^D),
and some even gained entrance to the cells during a 10 h
infection period. Similarly, cells from the other CF vF508
line (CFPAC) were also unable to mount a defense against
invading bacteria during a 10 h incubation period. Again, P.
aeruginosa surrounded the cells with a signi¢cant number ac-
tually gaining entry into the cell (Fig. 2E,F).
In order to ensure the validity of our conclusions, the rel-
ative capacities of several thousand normal and CF cells to
bind and permit bacterial entry as visualized by TEM of hor-
izontally cut thin sections, was monitored and quanti¢ed as
shown in Table 1. These extensive studies clearly demonstrate
a dramatic di¡erence between the capacity of normal and CF
cells to resist P. aeruginosa. Thus, binding and entry of these
bacteria into CF cells was signi¢cant (20% in CFTE cells and
50% in CFPAC cells), in sharp contrast to normal cells, where
after 10 h, bacterial binding could not be detected in V4000
cells examined, although 2 cells showed bacterial entry. It is
interesting to note that multiple bacteria tend to surround or
target particular CF epithelial cells at any one time rather




Quanti¢cation of epithelial cells having bound and entered P. aeruginosa
Cell type Number of cells
examined
Infection ratio: number
of bacterial cells to number
of epithelial cells
Number of cells with
bound P. aeruginosa
Number of cells with
entered P. aeruginosa
HTE V4000 1:1 0 2
CFTE V2000 1:1 V300 V100
CFPAC V2000 1:30 V700 V300
Cells were infected with P. aeruginosa exactly as described in Fig. 2. Horizontally cut thin sections of epithelial cells on 200 mesh copper grids were
scored by viewing with a Zeiss 10B transmission electron microscope (TEM). Of the total number of epithelial cells examined (¢rst column), the
percentage observed to have bacteria bound (fourth column) plus that observed to have bacteria entered (¢fth column), was 20% (CFTE cells) and
50% (CFPAC cells). An epithelial cell having either one or many bound bacteria was scored as one (fourth column). Also, an epithelial cell having
either one or many entered bacteria was scored as one (¢fth column). Signi¢cantly, multiple bacteria tend to surround or target particular CF
epithelial cells at any one time rather than making a concerted attack on the whole population of cells. (Approximate signs are used because some
small degree of error is expected when counting several thousand cells on multiple EM grids by eye).
Y.H. Ko et al./FEBS Letters 405 (1997) 200^208 203
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cells. At this time the reason for this is unknown but it may be
that other bacteria are alerted to a CF cell that has been
randomly penetrated by a single bacterium, or that bacteria
can `sense' the weakest members of the CF cell population,
perhaps cells in the process of dying.
Fig. 3 displays additional electron micrographs from our
TEM studies of horizontally cut thin sections of CF and nor-
mal cells after infection with P. aeruginosa. Several points
seem pertinent. First, three types of interactions of these bac-
teria with CF cells are commonly observed: binding (Fig. 3A),
encirclement by microvilli (Fig. 3B), and entrapment inside
the cells (Fig. 3C,D). Secondly, intracellular entrapment oc-
curs either within vacuoles (Fig. 3C) or within the cytoplasm,
usually in contact with an intracellular organelle (Fig. 3D).
The latter data leave no doubt that the bacteria have entered
the cell. Finally, although deep invaginations formed by enter-
ing bacteria may have occurred in some cases prior to intra-
cellular entrapment, this was not observed by careful exami-
nation of V4000 infected CF cells. In contrast, formation of
deep invaginations by bacteria was clearly observed in a few
normal cells (Fig. 3E,F) although the entry of bacteria (i.e.
actual entrapment inside the cells) was a very rare event (only
2 inV4000 cells, Table 1). These ¢ndings would suggest that
normal cells have a very high resistance to bacterial entry,
whereas this resistance has been severely compromised in
CF cells.
In order to ensure further the validity of our conclusions,
we performed TEM on vertically cut thin sections of both
normal and vF508 CF tracheal epithelial cells. In contrast
to horizontally cut thin sections (Fig. 2A^F), vertically cut
thin sections include the apical side of cells, thus allowing
surface interaction between epithelial cells and bacteria to be
FEBS 18334 25-10-97
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Fig. 3. Selected display of electron micrographs from normal and CF cells following 10 h exposure to P. aeruginosa. (A) A single P. aeruginosa
bacterium bound to the plasma membrane of a CFTE cell (magni¢cation= 14 800U) ; (B) a single bacterium bound to the plasma membrane
(PM) of a CFTE cell and encircled by microvilli (magni¢cation= 23 040U) ; (C) two bacteria entrapped inside a CFTE cell within a vacuole
(V) (magni¢cation= 6320U) ; (D) a single bacterium in contact with a mitochondrion inside a CFTE cell (magni¢cation= 6122U) ; (E,F) bacte-
ria penetrating HTE cells (normal cells) forming deep invaginations (magni¢cations= 26 730U and 25 740U, respectively). Where indicated,
PM=plasma membrane, N=nucleus, V= vacuole, ER= endoplasmic reticulum, M=mitochondrion. Arrows designate P. aeruginosa. Two ar-
rows indicate that the designated bacteria are within the cell.
Fig. 4. Ultrastructural analyses by TEM on vertically cut thin sections. Normal cultured tracheal epithelial cells after 10 h exposure to P. aeru-
ginosa completely clear the bacterial infection (panel in green), while cultured vF508 CF cells (CFTE cells, magenta) permit binding, entry, and
multiplication of these bacteria. The magni¢cation is, respectively, for normal cells and CF cells: 3539U and 2888U. The expanded bottom
right panel shows binding of a P. aeruginosa bacterium (magni¢cation: 10 193U) to a CFTE cell. See Section 2 for details. Arti¢cial coloration
was computer generated in order to enhance the contrast of the bacteria relative to the cellular background.
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observed. Fig. 4 presents TEM of vertically cut thin sections
of normal and CF cells 10 h after infection with P. aeruginosa.
The cuts were made through the central region of the cells. In
con¢rmation of results observed with horizontally cut thin
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Fig. 5. Expression of hTAP in NHBE cells. (A) An agarose gel (1.4%) demonstrating the RT-PCR ampli¢ed product of hTAP as depicted by
the arrow (220 bp from total RNA, lane 3) and from mRNA (lane 4). Control experiments were performed in the absence of templates (lanes
5,7) and in the presence of the template and the primers (lane 6) that were provided by Perkin Elmer. The PCR ampli¢ed product having the
expected size (308 bp) was observed (lane 6). Molecular weight standards of V-BstEII and BX174-HaeIII are shown in lanes 1 and 2, respec-
tively. (B) The RT-PCR ampli¢ed product of hTAP from total RNA of T84 cells (lane 1) or from total RNA of NHBE cells (lane 2) was ana-
lyzed by staining the 1.4% agarose gel with ethidium bromide solution (0.5 Wg/ml). Lane 3 corresponds to the DNA molecular weight standard,
BX174-HaeIII digest. (C) Nucleotide and predicted amino acid sequence of the RT-PCR ampli¢ed 220 bp product hTAP show its identity with
bTAP. The predicted normal human TAP amino acid sequence is illustrated with 3-letter codes and an asterisk (termination) below the bTAP
DNA sequence. The 5P and 3P primer sequences used for the RT-PCR experiment are underlined.
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sections, these vertical cuts show no sign of bacteria bound to
or within normal cells (top panel in green), but clearly reveal
bacteria bound to and within CF cells (lower panel in magen-
ta). Bacterial division also appears to occur within CF cells. It
is important to note that bacteria are only about 1 Wm in
diameter whereas epithelial cells are 40^50 Wm. Therefore,
the ¢nding that bacteria are observed in vertical sections cut
centrally through CF cells is compelling evidence that the
bacteria are inside the cell.
Although it is generally believed that P. aeruginosa do not
enter epithelial cells, the extensive TEM studies reported here
employing both horizontally and vertically cut thin sections,
indicate that this organism does gain entry into vF508 CF
cells in culture. The novel ¢nding of bacteria inside CF cells
may re£ect either the cells' ¢nal line of defense in a `last ditch
stand' to ¢ght back against an overwhelming microbial at-
tack, or their surrender to the invading bacteria.
Recently, it was reported that cultured human airway epi-
thelial cells expressing the vF508 allele of CFTR are defective
in uptake of P. aeruginosa [9], and that only normal cells have
the capacity to bind and allow entry of these infectious bac-
teria. Unfortunately, these investigators provided no electron
micrographs as visual support for their conclusions and the
`normal' cells used were derived from vF508 homozygous
cells that had been transfected with a plasmid containing
wild-type CFTR. In a more recent study [10], although the
preferential bactericidal action of normal airway epithelial
cells relative to CF cells is noted, a NaCl concentration
FEBS 18334 25-10-97
Fig. 6. Working model depicting how di¡erently normal and CF epithelial cells interact with P. aeruginosa. (A) Normal cells (a) are shown pre-
paring their ¢rst line of defense against invasion by P. aeruginosa (b). One or more antimicrobial peptides AP(s), perhaps hTAP, for destroying
the microbial organism may be secreted by a mechanism dependent on the normal function(s) of CFTR (b) and may function also inside the
cells against the entering P. aeruginosa (c). Consequently, infected cells ¢nally clear the bacteria (a). (B) CF cells having defective CFTR (a) are
infected with P. aeruginosa. Here, secretion of AP(s) which represent ¢rst line defense weapons, may be impaired or compromised (b). Thus,
the e¤ciency of bacterial clearance by CF cells is much less than that of normal cells resulting in increased bacterial binding, multiplication,
and entrance into cells (c), where killing by internally located AP(s) cannot keep pace with the rate of bacterial entry.
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(near 100 mM), in the normal physiological range for airway
surface £uid [14,15], was implicated as key factor for the bac-
tericidal action. Thus, in an experiment supported by limited
visual examination of CF cells, the presence of P. aeruginosa
was observed at a high but not a low Cl
3
concentration [10].
However, in the extensive study reported here, where V4000
CF cells were examined ultrastructurally after infection with
P. aeruginosa at a low `normal' NaCl concentration (104
mM), the capacity of these bacteria to bind and enter the
diseased cells was unimpaired (Table 1, Fig. 2B^F). Signi¢-
cantly, in a recent erratum [19], it is reported that the Cl
3
concentrations of 182 mM described by the above authors [10]
to be characteristic of CF nasal epithelial £uid is not repro-
ducibly observed. Therefore, the view [10] that CF cells can-
not mount a strong defense against invading bacteria is be-
cause the salt concentration in the surrounding airway surface
£uid is higher than normal requires further investigation.
In normal cells, the primary ¢rst-line defense against P.
aeruginosa may involve secretion of one or more antimicrobial
peptides. Signi¢cantly, we have shown by RT-PCR analysis
(Fig. 5A) that human tracheal epithelial cells express an
mRNA that corresponds closely to that of bovine TAP
(bTAP), known to exhibit bactericidal activity against P. aeru-
ginosa [20]. The expression of bTAP is reported to be speci¢c
to bovine airway mucosa, but not to several other tissues [21].
In humans, as in the bovine, the expression of the gene may
be speci¢c to the airway cells, as we have found it to be absent
in the colon carcinoma cell line, T84 (Fig. 5B) where bacter-
icidal activity is not necessary. The DNA sequence of the
human tracheal epithelial antimicrobial peptide (hTAP) is
identical to that of bTAP from Ala-9 to Arg-56 (Fig. 5C).
4. Conclusions
In summary, results of the present study using ultrastruc-
tural analysis by TEM clearly demonstrate that human tra-
cheal epithelial cells containing wild-type CFTR interact dif-
ferently with P. aeruginosa than vF508 CF cells, in which the
bacteria bind and enter the diseased cells. Moreover, normal
cells express the antimicrobial peptide hTAP, which is essen-
tially identical to bTAP and is known to kill P. aeruginosa.
This suggests a plausible working model (Fig. 6) to account,
at least in part, for how normal tracheal cells may clear P.
aeruginosa, whereas vF508 CF cells are unable to mount an
e¡ective defense. Thus, one or more antimicrobial peptides,
AP(s), one of which may be hTAP, may play a CFTR-de-
pendent role as part of a ¢rst line defense, functioning outside
of, or if necessary inside of, tracheal epithelial cells. This role
may be dramatically impaired or compromised in diseased
(vF508) cells. Work reported here is potentially very relevant
to the development of novel therapies to treat cystic ¢brosis
and many other lung diseases.
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